Neurofeedback During Eating for Bulimia Nervosa

Status Recruiting

Clinical Trial Summary

The purpose of this study is to examine the effects of noninvasive prefrontal cortex (PFC) neurofeedback during eating in women with bulimia nervosa (BN) using a wearable brain imaging device, functional near-infrared spectroscopy (fNIRS). The investigators will examine how this training may influence inhibitory control and BN symptoms.

Clinical Trial Description

The purpose of this study is to examine the effects of PFC neurofeedback during eating in women with bulimia nervosa (BN) using fNIRS. Specifically, the study aims 1) to demonstrate ventrolateral PFC (vlPFC) neurofeedback target engagement in women with BN using fNIRS; and 2) to link changes in PFC activation to changes in inhibitory control and eating-related symptoms. Data will be collected from women with BN who will be randomly assigned to one of two group conditions (real or sham-control neurofeedback during eating). Participation includes a phone screening assessment, psychodiagnostic assessment, one in-person evaluation, one neurofeedback session, behavioral tasks, online questionnaires before and after the neurofeedback session, and a remote follow-up assessment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05614024
Study type	Interventional
Source	Icahn School of Medicine at Mount Sinai
Contact	Jessica Qiu, B.A.
Phone	212-201-2679
Email	jessica.qiu@mssm.edu
Status	Recruiting
Phase	N/A
Start date	April 2024
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04174703` - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing	N/A
Terminated	`NCT04278755` - Binge Eating & Birth Control	Phase 2
Withdrawn	`NCT02978742` - Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder	N/A
Withdrawn	`NCT00988481` - Topiramate Augmentation in Bulimia Nervosa Partial Responders	Phase 4
Completed	`NCT00522769` - Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents	Phase 1/Phase 2
Completed	`NCT00184301` - A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder.	N/A
Completed	`NCT00304187` - Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa	Phase 2
Recruiting	`NCT04409457` - Self-Control in Bulimia Nervosa	N/A
Recruiting	`NCT05509257` - Naltrexone Neuroimaging in Teens With Eating Disorders	Early Phase 1
Recruiting	`NCT05862389` - Study on the Mechanism of Eating Disorder
Recruiting	`NCT05937243` - Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating	N/A
Recruiting	`NCT05728021` - Smartphone-based Aftercare for Inpatients With Bulimia Nervosa	N/A
Completed	`NCT03781921` - The Neural Bases of Emotion Regulation in Bulimia Nervosa
Completed	`NCT02553824` - FDA Approved Medication to Reduce Binge Eating and/or Purging	Phase 1
Terminated	`NCT04041024` - Decision-making and Risk-taking in Bulimia	N/A
Completed	`NCT04265131` - Emotion Regulation in Eating Disorders: How Can Art Therapy Contribute to Treatment Outcome?	N/A
Recruiting	`NCT06431854` - Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program	N/A
Recruiting	`NCT02960152` - Periodontal Impact of Eating Disorders (the PERIOED Study)	N/A
Completed	`NCT00916071` - Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders	N/A
Terminated	`NCT00308776` - Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa	N/A